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INTRODUCTION
From ancient civilizations to modern technocratic society, humanhealth has been a burning issue that troubled all people. In 300 BC,
the Greek anatomist and surgeon Herophilus of Chalcedon wrote: »To
lose one’s health renders science null, art inglorious, strength unavail-
ing, wealth useless, and eloquence powerless«. In a poll conducted by
the Gallup Institute in 1999 among 50000 individuals from 60 different
countries, the majority of respondents chose good health as the most
valued entity among such categories as job, education, freedom, good
health, happy family, etc.
Cardiovascular diseases (CVD) are diseases and injuries of the car-
diovascular system: the heart, the blood vessels of the heart, and the sys-
tem of blood vessels throughout the body and within the brain. CVD
are the leading cause of deaths (1). In 2003, CVD killed 16.7 million
people worldwide, which constitutes 29.2% of total deaths according to
the World Health Report. Interestingly, CVD became the leading cause
of death in developed countries from the middle of the 20th century,
and since 2001 they have become the leading cause of death in the de-
veloping world (2, 3). Nearly half of all deaths in developed countries
and approximately 28% of deaths in low- and middle-income (develop-
ing) countries are the result of CVD (3). Thirty-six per cent of deaths in
North America are due to CVD, whereas in Europe CVD cause over
4.35 million deaths annually, i.e. 49% of all deaths. Epidemical charac-
ter of heart disease and stroke is reflected in increase in personal, com-
munity and health care costs. In Canada, CVD is the underlying cause
of death for one in three Canadians. Eight in ten Canadians have at
least one risk factor for CVD and 11% have three risk factors or more
(4). CVD have the largest economic impact of all illnesses in Canada.
In 1998, Health Canada estimated the total cost to the health sector and
the Canadian economy to be approximately 18.5 billion dollars (5).
ENVIRONMENTAL CARDIAC RISK FACTORS
About sixty years ago, Framingham Heart Study first identified three
key cardiac risk factors: high blood pressure, high cholesterol and smok-
ing. Before that, it was generally thought that heart attacks come out of
nowhere without any apparent reason. Even high blood pressure was
considered as a part of the normal aging process. Later, three more risk
factors, such as physical inactivity, obesity, and diabetes were recognized
as major cardiovascular risk factors. Although cardiovascular risk factors
most often appear in clusters, there are data indicating that hypertension
is present in over 85% of patients who develop heart failure (6).
Environmental factors are also considered as key determinants of
CVD (7). Initially, a significance of environmental factors in CVD was
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demonstrated in the Seven Countries Study started in
1958 on three continents, North America, Europe, and
Asia (8). The Study detected up to five-fold differences in
prevalence, incidence of and mortality from CVD among
populations with various geographic, ethnic, and cultural
characteristics. The above features would be approxi-
mately equal, if only normal aging was a factor. Higher
incidence rates were found in North America and north-
ern Europe comparing to southern Europe and Japan.
The incidence of CVD is also not evenly distributed in
the USA according to the findings published in 2007 by
the Center for Disease Control and Prevention, Atlanta,
GA (9). Based on telephone interview of 350000 partici-
pants throughout the USA, the report showed that West
Virginia, Puerto Rico, and Kentucky have the highest pro-
portion of residents with heart disease, whereas Hawaii,
Colorado, and the US Virgin Island have the lowest.
Although lifestyle choices such as smoking, diet, and
exercise are viewed as major environmental factors, there
is accumulating evidence suggesting that exposure to
pollutants and chemicals could elevate the risk of CVD.
For example, postmenopausal women in the USA, re-
gardless of any risk factors for cardiovascular disease,
were found to be at increasing risk of fatal and non-fatal
cardiovascular events with greater long-term exposure to
the fine particulate air pollution, PM2.5, i.e., airborne
particles < 2.5 mm in diameter (10). It was shown that
there was a 24% increase in any CV event, 76% jump in
CV mortality, and more than double increase in mortal-
ity from any later diagnosed coronary heart disease for
every 10 mg/m3 rise in particulate air-pollution concen-
trations. Interestingly, such level of PM2.5 pollution is
not unusual. As a matter of fact, the levels of PM2.5 expo-
sure in the USA in 2000, varied from the lowest 3.4 (ob-
served in Honolulu) to the highest 28.3 (Riverside, Cali-
fornia) with the mean of 13.5 mg/m3, and the National
Ambient Air Quality Standard required by the Clean Air
Act of the USA is 15 mg/m3 PM2.5 (11).
The study of 4494 adults aged 45 to 74 years showed
that living near busy roads increases incidents of coro-
nary atherosclerosis (12). Recently, first evidence of causal
link between brief exposure to diesel fumes during physi-
cal exercise and myocardial infarction has been obtained
(13).
Above mentioned outcomes have only recently been
observed and the correlation between human exposure
to environmental chemical pollution and cardiovascular
events remains to be investigated in more details. More
than 80000 chemicals are currently registered in the
United States for commercial use, and the influence on
CVD of only few of them has been examined (7). The in-
creasing use of nanomaterials is another area of emerg-
ing concern (14). Exposures to arsenic, lead, cadmium,
pollutant gases, solvents, and pesticides have been linked
to increased incidence of CVD (7, 15). The death rates
for certain types of CVD have been found to be higher in
soft water areas than in hard water areas in many parts of
the world (15, 16, 17, 18). It is thought that at lower con-
centration of calcium and magnesium, which are essen-
tial elements determining most water hardness, heavy
metal ions, e.g. lead, are better absorbed by humans. A
significant protective effect of calcium intake from drink-
ing water on the risk of death from acute myocardial in-
farction has been shown (19). An association between
dementia (including Alzheimer’s disease) and high con-
centrations of aluminum in drinking water is suggested
especially for the most elderly (20). Also, an unusually
high incidence of Lou Gehrig’s and Parkinson’s diseases
in indigenous populations in Guam and New Guinea
suggests a possible correlation between the diseases and
local environmental conditions, including high levels of
aluminum and low levels of calcium and magnesium in
soil and food (20).
In this perspective, I will briefly review pathophysio-
logical effects of lead exposure with emphasis on cardio-
vascular system and the major sources of human expo-




Lead occurs naturally in the environment and has
many industrial uses. However, even small amounts of
lead can be hazardous to human health. One gram of
lead in 20000 liters of water makes it unfit for drinking.
In extreme cases, short-term exposure to high levels of
lead can cause vomiting, diarrhea, paralysis, convulsive
seizures, coma or even death (21). Acute lead poisoning
causes various symptoms related to the nervous system:
headache, irritability, abdominal pain, sleeplessness, rest-
lessness; children may be affected by behavioral distur-
bances, learning and concentration difficulties. In severe
cases, the affected person may suffer from acute psycho-
sis, confusion and reduced consciousness (22). Symp-
toms of long-term exposure to lower lead levels may be
less noticeable but are still serious.
Association between lead exposure and CVD in hu-
man population was recently reviewed by Navas-Acien et
al. (23). In several clinical trials and population studies,
occupational exposure to lead was shown to correlate with
increased incidence of hypertension, cerebrovascular and
cardiovascular disease (24, 25). Cardiotoxic effects of lead,
for which positive association with lead exposure has been
suggested, are as follows. Lead causes peripheral arterial
occlusive disease and, possibly, direct myocardial injury.
Lead poisoning is associated with myocarditis and sinus
bradycardia. EKG abnormalities are reported for children
and lead-exposed workers. Lead promotes hydroxyl radi-
cal generation and lipid peroxidation in cultured aortic
endothelial cells and may induce the procoagulant activity
of blood cells directly leading to thrombosis. Lead affects
both human erythrocytes and lymphocytes (26). In eryth-
rocytes, it could degenerate the lipid and protein compo-
nents and suppress hemoglobin synthesis.
Besides cardiovascular outcomes, lead has detrimen-
tal effects on the central nervous, gastrointestinal, repro-
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ductive, renal and immune systems (22). In the brain,
lead has toxic effects on neurons, vascular endothelial
cells, astroglia, and oligodendroglia. It induces apoptosis
and excitotoxicity, as well as disturbances in the storage
and release of neurotransmitters and second messengers.
Long-term exposure to lead causes memory deteriora-
tion, prolonged reaction time and reduced ability to un-
derstand. It reduces nerve conduction velocity and der-
mal sensibility. Lead exposure diminishes intellectual
capacity in children. For every 10 mg/dL increase in
blood lead, IQ decreases by 2 points (27). Notably, the
mean IQ in the USA is 100 and people with IQ less than
70 are considered to be mildly mentally retarded.
Chronic inorganic lead toxicity results in growth re-
tardation, intellectual impairment, and hyperactivity
(21). Developmental exposure to lead upregulates the
expression level of amyloid precursor protein involved in
Alzheimer’s disease (28). Other adverse effects of lead in-
clude: loss of muscle tone, intestinal colic, anemia, spon-
taneous abortion, possibly cancer (lung cancer, stomach
cancer and gliomas), increase in oxidative stress, down
regulation of nitric oxide production, interference with
vitamin D metabolism and magnesium, calcium, iron
and zinc homeostasis, etc.
Lead exposure is most serious for young children be-
cause they absorb lead more easily than adults and are
more susceptible to its harmful effects. Even low level ex-
posure may harm the intellectual development, behav-
iour, size and hearing of infants. During pregnancy, es-
pecially in the last trimester, lead can cross the placenta
and affect the unborn child. Female workers exposed to
high levels of lead have more miscarriages and stillbirths.
Sufficient evidence has been accumulated to assume a
causal relationship between blood lead level (BLL) and
various pathologies. From geochemical data, natural
BLL should be at 0.25 mg/dL (29). At this level, lead
probably does not cause any harm to humans. At higher
concentrations, lead causes a variety of diseases includ-
ing CVD. Elevated BLL (20-29 mg/dL) correlates with
significant increases in all-cause circulatory and cardio-
vascular mortality (30). Although high blood pressure
was previously found to be associated with increased
BLL (31, 32), in some studies positive correlation be-
tween clinical cardiovascular events and lead exposure
was observed at BLL < 5 mg/dL (23). Positive dose-re-
sponse relationship between low-level exposure mani-
fested by blood levels < 40 mg/dL and blood pressure was
observed (33). Delayed responses in central nervous sys-
tem electrophysiology were related to BLL as low as 15
mg/dL (34). At blood concentration of 33 mg/dL, lead im-
pairs skin wound healing (35). Impaired cognitive func-
tioning and academic achievement were reported among
children with BLL below 5 mg/dL (36). Workers could
have an average blood lead level of 60.6 ± 8.0 mg/dL, and
individuals with average blood lead levels under 63
mg/dL showed signs of peripheral nerve symptoms with
reduced nerve conduction velocity and reduced dermal
sensibility.
Notwithstanding the above findings, there is evidence
that current BLLs do not reflect total body burden (37).
In fact, total lead body burden is mainly represented by
bone stores, and bone lead is a better biological marker in
chronic lead toxicity. Simple calculations to follow to
demonstrate that even small BLL, which are quite com-
mon for everyday life, are dangerous for human health.
Lead enters human body mainly through gastrointesti-
nal tract and respiratory ingestion. In the USA, at the end
of 1980s, an average adult digested about 250-300 mg lead
per day in food and beverages (38, 39). About 33% came
from food, 16% – from drinking water, 49% – from canned
beverages, and 2.5% – from canned food. Notably, in
1970s, the threshold level required for bioaccumulation of
lead was estimated to be 100 mg lead per day for infants
and 300 mg lead per day for children (40). Digested inor-
ganic lead should overcome hydrophobic barrier to get
into the blood. Since specific cellular transporters for lead
are unlikely as this metal is nonessential and toxic, lead
ions could take the pathways reserved for essential metal
ions such as calcium, iron, etc. Indeed, it was shown (41)
that intestinal transporter for Fe2+ ions, DMT1, mediates
the transmembrane movement of Pb2+.
In Cincinnati in 1960s, the average adult had a respi-
ratory ingestion of 30 to 40 mg per day (39). With 10% of
the ingested lead being absorbed from gastrointestinal
tract and up to 50% of inhaled inorganic lead being ab-
sorbed in the lungs (39), the average combined lead daily
body uptake is about 50 mg. Since average adult human
body contains about 5 liters of blood and half-life for lead
in the blood is about one month (27), the above daily lead
uptake results in about 1 mg/dL as a minimal sustained
BLL. At first glance, that concentration looks harmless as
it is much smaller than the alert levels set by US OSHA
(Occupational Safety and Health Association) and other
authorities (40 mg/dL for general population and 10
mg/dL for children and pregnant women). Notably, pos-
sible uptake of tetraethyl lead and tetramethyl lead,
which can easily penetrate the skin (35, 42), was not
taken into consideration here.
Once in organism, lead binds mainly to erythrocytes
and then moves from the blood to other organs. Lead
could be distributed in various tissues and organs includ-
ing the kidney, liver, spleen, heart, stomach, intestine,
bones, and nervous and reproductive systems (22). How-
ever, 90-95% of adult body lead burden resides in bones.
Human bones mainly consist of calcium orthophosphate
(e.g. hydroxyapatite [3Ca3(PO4)2 • Ca(OH)2]), which
makes up to 60% of the weight of the human skeleton,
comprising 99% of the total calcium of the human body
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The above equilibria are characterized by solubility
products, SP. The deposit cannot be formed, if this prod-
uct is less than SP. The following equation allows calcu-
lating at what concentration in blood lead is not depos-
ited in bones:
The values of corresponding SPs could be found in
(44, 45). It follows from the calculation that lead is not
accumulated in bones at BLL half-million times less
than that of calcium. Physiological blood calcium con-
centration is about 2.4 mM (46). Thus, BLL should not
exceed 0.1 mg/dL. Since the above estimated BLL from
daily uptake is about 1 mg/dL, lead is permanently accu-
mulated in human bones. Although presented calcula-
tion seems quite approximate, it probably has certain
merits. Firstly, it closely relates to the natural BLL from
geochemical data. Secondly, no threshold value for asso-
ciation between blood pressure and the lowest level of
lead exposure has been found yet (23).
It is estimated that about 70% of blood lead comes
from skeleton (22). The half-life of lead in bones ranges
from a few years in trabecular bone (e.g. the patella) to
decades in cortical bone (e.g the tibia) (47). Therefore, in
some instances, bones could provide elevated BLL com-
paring to lead from daily uptake and serve as an endoge-
nous source of lead exposure in people with increased
bone turnover (48). Although both tibia and patella lead
were associated with an elevated risk of hypertension,
stronger correlation between tibia lead and hypertension
was observed (33, 49). Blood lead level could signifi-
cantly increase when bones become less stable. For ex-
ample, elderly individuals are experiencing significant
bone loss (up to 50% for 70-year-old persons) due to os-
teoporosis. During pregnancy, it may double due to mo-
bilization from bones. Notably, fetus actively (i.e. against
concentration gradient) absorbs calcium and, simulta-
neously, lead from mother. Bone loss in postmenopausal
women and in aged persons could also cause the elevated
BLL. In women, lead liberated from the bone as a result
of postmenopausal bone loss causes an increase in both
systolic and diastolic blood pressures and elevates the risk
of hypertension (32).
MAJOR SOURCES OF LEAD
CONTAMINATION
Lead is ubiquitous in nature and is introduced into
living organisms, including the human body, from envi-
ronment. The total amount of lead that has been dis-
persed to the world ecosystems through the atmosphere
during last 2000 years is 20•109 kg (50, 51). If that
amount was uniformly distributed over the Earth sur-
face, which is 510,065,600 km2, then the average surface
concentration of lead would constitute about 40 kg/km2.
Thus, despite the efforts of developed countries from the
early 1970s to reduce lead exposure by the introduction
of unleaded gasoline and banning lead-based paint and
lead solder in food cans, there is quite a substantial
amount of lead accumulated in environment over the
years, and this lead could be re-introduced into the atmo-
sphere or dissolved in aquatic systems due to various me-
teorological events and anthropogenic activities.
The major sources of lead exposure include: dietary
lead from food and drinks, including drinking water,
dust and air emissions. In natural water, typical lead con-
centration lies between 0.2 and 1 mg/dL (52). However,
drinking water can acquire more lead at the original wa-
ter source, during treatment and/or distribution through
the plumbing system. About 16% of lead body uptake
come from drinking water (38). A close correlation be-
tween the lead concentration in tap water and BLL was
found in Hamburg, Germany (53). Data from Glasgow
and Liverpool indicated that over 10% of people exposed
to an average water lead concentration of 10 mg/dL would
have BLL above 25 mg/dL (54). It was known at least
2000 years ago from a Roman architect Vitruvius (ca. 27
BC to AD 14) that »water should not be brought in lead
pipes, that is if we desire to have it wholesome«. Never-
theless, in 1982 in Great Britain about 45% households
used water which had at some stage passed through lead
pipes (55). Some properties in Scotland, in 1970s, had
lead-lined water tanks in 1970s (55). About 100000-120000
apartments in Hamburg, Germany, (53) and 70000 in
Paris, France, (56) use lead-containing plumbing and are
supposed to be supplied with lead contaminated water.
In 1993, lead pipes were in use in some 50% of the houses
in southern Saxonia, Germany (57). Thereat, the me-
dian and maximum lead levels in tap water were 2.4 and
260 mg/dL, respectively. In a study conducted in house-
holds in Trondheim, Norway, the highest values of lead
were found in hot water from heaters, especially in older
houses with old water heaters (58). In 1975-76, 10% of
households in England and Wales, and over one-third in
Scotland had 'random daytime' water lead concentra-
tions above 5 mg/dL (55).
In the USA, drinking water is responsible for approxi-
mately 20% of the total daily lead exposure experienced
by the majority of population (22). The use of lead solder
and leaded pipes from public water supply systems and
plumbing was banned in 1986 by the amendments to the
federal Safe Drinking Water Act, and lead content in fau-
cets and other brass plumbing components was limited
to no more than 8%. Nevertheless, leaded plumbing
components continue to be used in schools and daycares
creating a significant contribution to lead in drinking
water in these buildings. In many Seattle Public Schools,
the elevated water lead concentration (>2 mg/dL) was
found in 2004 (59). In Philadelphia, 57.4% of public
schools had water lead levels exceeding US EPA action
level of 2 mg/dL, and 28.7% of schools had water lead lev-
els in excess of 5 mg/dL (60). Interestingly, the EPA juris-
diction does not extend to drinking water in public
school buildings (61) and EPA only provides the non-en-
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forceable guideline for school that recommends that
drinking water lead does not exceed 2 mg/dL.
Traces of lead are found in almost all food (38). Lead
can enter food from lead-based glazes on glassware and
ceramics, from containers painted with lead-based paint
or from vinyl lunchboxes (22). Elevated BLL was found
to be associated with storing of food in lead-glazed con-
tainers (62), whereas children’s lunchboxes made of soft
vinyl were found to contain more than 90 times the legal
limit for lead in paint (63). Lead solder used in canned
food produced outside the USA and Canada can also
contaminate food (64). Leaded crystal glassware could
also be a significant source of dietary lead, especially
when acidic beverages such as wine, port, fruit juices and
soft drinks are served.
Dust and soil represent a significant source of lead
contamination, especially for young children and work-
ers exposed to lead. Lead in soil comes from the air or
from erosion of lead-bearing rocks. Workers in smelters,
refineries and other industries and their families living in
the vicinity to these industrial enterprises may be ex-
posed to high levels of lead. For example, in children liv-
ing in highly industrialized city of Duisburg, Germany,
BLL was higher (3.1 mg/dL) than in those from the rural
area of North Rhine Westphalia, Germany, (2.1 mg/dL)
(65). In another case, villagers from Campo de Jales, Por-
tugal, a village surrounding the abandoned Jales mine,
had a significantly higher than usual BLL levels that was
associated with increased prevalence of respiratory and
irritation symptoms (66). Kidney damage in Egyptian
policemen was positively correlated with duration of lead
exposure from automobile exhaust (67).
Lead-containing dust can be generated from lead-bas-
ed paints. Most indoor and outdoor paints produced be-
fore 1950 contained substantial amounts of lead which
sometimes reached 3.8% (68). The lead content of exterior
paint is still not regulated. In the USA, lead-based paint
covers five billion square feet of non-residential surface
area and almost 90% of bridges (22). It is estimated that 38
million homes in the USA contain lead paint. Lead dust
can also be generated within the home, especially older
homes that used lead-based paints or lead solder.
Atmospheric lead emission and deposition represent
the greatest health concern, because of the quantities in-
volved and the widespread dispersion. Airborne lead can
be deposited on water bodies, soil and crops, thus enter-
ing the animal and, eventually, human food chain. It was
shown that 7-40% of the lead in blood is airborne by ori-
gin (68).
Although the use of leaded gasoline has decreased
dramatically in the developed countries, it is still in use in
developing countries and tetraethyl lead remains a com-
mon additive to petrol. Leaded gasoline is still legally al-
lowed in aircraft, watercraft, and farm machinery (22).
Lead is also released into air through industrial emis-
sions, smelters, refineries and battery plants.
An average residential time of lead in atmosphere is
about 4-6 weeks, during which lead can travel long dis-
tances and be mostly uniformly distributed over space.
The evidences of this has been found in ancient and mod-
ern times. For example, lead contents of ice layers depos-
ited in Greenland between 500 B.C. and 300 A.D. were
about 4 times that of background, implying widespread
pollution of the Northern Hemisphere by emissions from
Roman mines and smelters (69). Also, correlation between
chronology of anthropogenic lead emission and the lead
content in seal hair, penguin droppings and snow was
found in Antarctica (50). In individuals living in remote
regions of the Himalayas with no known lead exposure,
BLL was found to be 0.78-3.2 mg/dL, whereas current me-
dian BLL in U.S. adults, ages 20-59, tested in 1999-2002
was 1.5 mg/dL (22). Atmospheric lead deposition strongly
depends on weather pattern. For example, two samples of
the air collected in Sutton, in vicinity of London, UK, on
two different days in the same year contained 29 mg and
7733 mg of Pb per gram of air dust (70). It was raining on
both days. This 267-fold difference was due to the fact that
wind on the first day was from south-west, and on the sec-
ond day wind was from north-east and London air was
carried over Sutton. Interestingly, Sutton once in a while
becomes covered by a thin grey-white deposit originating
from the Sahara desert in North Africa. On one particular
day, about one million ton of Sahara’s dust was deposited
over southern England and Wales (70).
The data on atmospheric lead emission and deposi-
tion over European and Trans-Caucasian countries and
Kazakhstan could be found on the website http://www.
msceast.org/hms/emission.html#Spatial (accessed in
January 2008), managed by the Meteorological Synthe-
sizing Center-East (MSC) located in Moscow, Russia.
The MSC is an international center of Co-operative Pro-
gram for Monitoring and Evaluation of Long-Range
Transmission of Air Pollutants in Europe (EMEP).
The detailed analysis of the MSC data shows that Eu-
ropean countries unequally emit lead (Figure 1). The at-
mospheric lead emission in most countries in 2004 was
less than 0.5 kg/y/km2. However, atmospheric lead depo-
sition to a specific country is not proportional to emis-
sion, which reflects its strong dependence on weather
conditions. As a matter of fact, atmospheric lead deposi-
tion is normally distributed over 34 European countries,
with most countries getting about 1 kg/y/km2 (Figure 2).
This suggests pretty good air mixing over Europe. It is of
interest to calculate the »lead gain« for each country, i.e.
the ratio of atmospheric deposition over the emission. If
the gain is more than one, the country gets more lead
than it emits, and on the contrary, if the gain is smaller
than one, then it country gets less than emits. The results
of such calculation are presented in Figure 3. It is evident
that most countries acquire more atmospheric lead than
is their emission. Notably, Iceland gets 276 times more
atmospheric lead than it emits, whereas, at the other end,
Portugal gets 3 times less than emits. These data suggest
the necessity of tight collaboration and cooperation in
fighting against atmospheric pollution.
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CONCLUSION
Although there is growing evidence of pathological, in
general, and cardiotoxic, in particular, effects of lead, its
role as one of the cardiovascular risk factors is not widely
recognized. One of the reasons for this is that mecha-
nisms of the harmful activity of lead are not fully under-
stood. Understanding of these mechanisms would place
lead among all other widely recognized cardiovascular
risk factors and help to develop specialized therapy
to prevent its harmful influences. At present, it is not
even known whether chemical pollutants influence ma-
jor risk factors, such as hypertension, cholesterol content
or diabetes, or they represent absolute risk for heart dis-
ease (7). For this purpose, futher investigations are ur-
gently needed.
The necessity to study the mechanisms of biological ac-
tion of toxic metals comes also from realization that the
more we know about lead and the more we understand
the mechanisms of its toxicity, the more accurately we can
decide what level of BLL is really safe. The advisory BLL
established by US OSHA has been gradually decreased
over the past few decades, from 60 mg/dL (1960-1970), to
30 mg/dL (1970-1985), to 25 mg/dL (1985-1991), to 10
mg/dL (1991) (71), as the new data on adverse health effects
of lead poisoning became available. Recent data indicate
that BLL, especially in children, should be reduced even
below the 1991 level. For example, it was shown that blood
lead and cadmium, at levels well below current safety
standards established by OSHA, were associated with an
increased prevalence of peripheral arterial disease (72).
In a socio-political sphere, dissemination and popular-
ization of obtained scientific results is also necessary to
raise the level of public awareness, since the awareness of
ill effects of lead is not widespread. Also, better internatio-
nal environmental regulations and tighter collaboration
between countries should be implemented on a global
scale to eliminate transboundary atmospheric pollution.
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Figure 1. Distribution of European countries according to the amount
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Figure 2. Distribution of European countries according to the amount
of atmospheric lead deposition. Dashed line represents the best least-






























































































































































































































Figure 3. The »lead gain« by European countries. The dashed line corresponds to the ratio that equals unity.
REFERENCES
1. MURRAY C J L, LOPEZ A D 1996 The global burden of disease: a
comprehensive assessment of mortality and disability from diseases,
injuries, and risk factors in 1990 and projected to 2020. Cambridge
(MA), Harvard University Press.
2. ALAN DLOPEZ, COLIN D MATHERS, MAJID EZZATI, DEAN
T JAMISON, CHRISTOPHER J L MURRAY 2006 The global
burden of disease and disability and risk factors. Oxford, Oxford
University Press.
3. MATHERS C D, LOPEZ A D, STEIN C, MA FAT D, RAO C,
INOUE M, SHIBUYA K, TOMIJIMA N, BERNARD C, XU H
2003 Deaths and disease burden by cause: global burden of disease
estimates for 2001 by World Bank country groups. Washington, The
World Health Organization (WHO), the World Bank, and the
Fogarty International Center, U.S. National Institutes of Health
(NIH). DCPP Working Papers Series No. 18, Second Project on
Disease Control Priorities in Developing C ountries (DCPP).
4. HEART AND STROKE FOUNDATION OF CANADA 2003
The Growing Burden of Heart Disease and Stroke in Canada 2003.
Ottawa, Canada.
5. HEALTH CANADA 2002 Economic Burden of Illness in Canada,
1998. Ottawa, Canada.
6. HO K K, PINSKY J L, KANNEL W B, LEVY D 1993 The epide-
miology of heart failure: the Framingham Study. J Am Coll Cardiol
22: 6A–13A
7. BHATNAGAR A 2006 Environmental cardiology: studying mecha-
nistic links between pollution and heart disease. Circ Res 99: 692–705
8. KFOMHUT D, MENOTTI M, BLACKBURN H 2002 Preven-
tion of Coronary Disease, Diet, Lifestyle, and Risk Factors in the
Seven Countries Study Norwell. Kluwer Academic Publishers, MA.
9. NEYER J R, GREENLUND K J, DENNY C H, KEENAN N L,
LABARTHE D R, CROFT J B 2007 Prevalence of Heart Disease-
United States, 2005. MMWR Morb Mortal Wkly Rep 56: 113–118
10. MILLER K A, SISCOVICK D S, SHEPPARD L, SHEPHERD K,
SULLIVAN J H et al. 2007 Long-term exposure to air pollution and
incidence of cardiovascular events in women. N Engl J Med 356:
447–458
11. US Environmental Protection Agency 2007 AirData: Access to Air
Pollution Data. http://www.epa.gov/oar/data/.
12. HOFFMANN B, MOEBUS S, MOHLENKAMP S, STANG A,
LEHMANN N et al. 2007 Residential exposure to traffic is associ-
ated with coronary atherosclerosis Circulation 116: 489–496
13. MILLS N L, TORNQVIST H, GONZALEZ M C, VINK E,
ROBINSON S D et al. 2007 Ischemic and thrombotic effects of di-
lute diesel-exhaust inhalation in men with coronary heart disease. N
Engl J Med 357: 1075–1082
14. NEL A, XIA T, MADLER L, LI N 2006 Toxic potential of materials
at the nanolevel. Science 311: 622–627
15. SHARRETT A R 1979 The role of chemical constituents of drinking
water in cardiovascular diseases Am J Epidemiol 110: 401–419
16. COMSTOCK G W 1979 Water hardness and cardiovascular dis-
eases. Am J Epidemiol 110: 375–400
17. NERBRAND C, AGREUS L, LENNER R A, NYBERG P,
SVARDSUDD K 2003 The influence of calcium and magnesium in
drinking water and diet on cardiovascular risk factors in individuals
living in hard and soft water areas with differences in cardiovascular
mortality. BMC Public Health 3: 21–25
18. KOUSA A, MOLTCHANOVA E, VIIK-KAJANDER M, RYTKO-
NEN M, TUOMILEHTO J et al. 2004 Geochemistry of ground
water and the incidence of acute myocardial infarction in Finland. J
Epidemiol Community Health 58: 136–139
19. YANG C Y, CHANG C C, TSAI S S, CHIU H F 2006 Calcium and
magnesium in drinking water and risk of death from acute myocar-
dial infarction in Taiwan. Environ Res 101: 407–411
20. HEALTH CANADA 2006 Guidelines for Canadian Drinking Wa-
ter Quality. http://www.hc-sc.gc.ca/ewh-semt/water-eau/drink-potab/
aluminum-aluminium_e.html.
21. REGUNATHAN S, SUNDARESAN R 1985 Effects of organic and
inorganic lead on synaptosomal uptake, release, and receptor bind-
ing of glutamate in young rats. J Neurochem 44: 1642–1646
22. PATRICK L 2006 Lead toxicity, a review of the literature. Part 1: Ex-
posure, evaluation, and treatment. Altern Med Rev 11: 2–22
23. NAVAS-ACIEN A, GUALLAR E, SILBERGELD E K, ROTHEN-
BERG S J 2007 Lead exposure and cardiovascular disease – a sys-
tematic review Environ Health Perspect 115: 472–482
24. FANNING D 1988 A mortality study of lead workers, 1926-1985.
Arch Environ Health 43: 247–251
25. SOKAS R K, SIMMENS S, SOPHAR K, WELCH L S, LIZIEW-
SKI T 1997 Lead levels in Maryland construction workers. Am J Ind
Med 31: 188–194
26. SLOBOZHANINA E I, KOZLOVA N M, LUKYANENKO L M,
OLEKSIUK O B, GABBIANELLI R et al. 2005. Lead-induced
changes in human erythrocytes and lymphocytes. J Appl Toxicol 25:
109–114
27. WORLD HEALTH ORGANIZATION 1995 Lead. Environmen-
tal Health Criteria Geneva: World Health Organization V.165
28. BASHA M R, MURALI M, SIDDIQI H K, GHOSAL K, SIDDIQI
O K et al. 2005 Lead (Pb) exposure and its effect on APP proteolysis
and Ab aggregation. FASEB J 19: 2083–2084
29. PATTERSON C C 1965 Contaminated and natural lead environ-
ments of man Arch Environ Health 11: 344–360
30. LUSTBERG M, SILBERGELD E 2002 Blood lead levels and mor-
tality. Arch Intern Med 162: 2443–2449
31. BEEVERS D G, ERSKINE E, ROBERTSON M, BEATTIE A D,
CAMPBELL B C et al. 1976 Blood-lead and hypertension. Lancet 2:
1–3
32. NASH D, MAGDER L, LUSTBERG M, SHERWIN R W, RUBIN
R J et al. 2003 Blood lead, blood pressure, and hypertension in pe-
rimenopausal and postmenopausal women. JAMA 289: 1523–1532
33. HU H, ARO A, PAYTON M, KORRICK S, SPARROW D et al.
1996. The relationship of bone and blood lead to hypertension. The
Normative Aging Study. JAMA 275: 1171–1176
34. MCMICHAEL A J, BAGHURST P A, WIGG N R, VIMPANI G V,
ROBERTSON E F, ROBERTS R J 1988 Port Pirie Cohort Study:
environmental exposure to lead and children’s abilities at the age of
four years. N Engl J Med 319: 468–475
35. LANSDOWN A B 1995. Physiological and toxicological changes in
the skin resulting from the action and interaction of metal ions. Crit
Rev Toxicol 25: 397–462
36. LANPHEAR B P, DIETRICH K, AUINGER P, COX C 2000 Cog-
nitive deficits associated with blood lead concentrations <10 mg/dL
in US children and adolescents. Public Health Rep 115: 521–529
37. HU H, RABINOWITZ M, SMITH D 1998 Bone lead as a biologi-
cal marker in epidemiologic studies of chronic toxicity: conceptual
paradigms. Environ Health Perspect 106: 1–8
38. GALAL-GORCHEV H 1993 Dietary intake, levels in food and esti-
mated intake of lead, cadmium, and mercury. Food Addit. Contam
10: 115–128
39. GOLDSMITH J R, HEXTER A C 1967 Respiratory exposure to
lead: epidemiological and experimental dose-response relationships.
Science 158: 132–134
40. MORSE D L, WATSON W N, HOUSWORTH J, WITHERELL
L E, LANDRIGAN P J 1979 Exposure of children to lead in drink-
ing water. Am J Public Health 69: 711–712
41. BRESSLER J P, OLIVI L, CHEONG J H, KIM Y, BANNONA D
2004. Divalent metal transporter 1 in lead and cadmium transport.
Ann N Y Acad Sci 1012: 142–152
42. JARUP L 2003 Hazards of heavy metal contamination. Br Med Bull
68: 167–82
43. KREBS J, HEIZMANN W 2007 Calcium-binding proteins and the
EF-hand principle. In: Krebs J, Michalak M (eds) Calcium: A matter
of life or death. Elsevier, p 51–93
44. NRIAGU J O 1972 Lead orthophosphates. I. Solubility and hydroly-
sis of secondary lead orthophosphate. Inorganic Chemistry 11: 2499–
2503
45. OMELCHENKO A 1991 Physico-chemical basis of specificity of
metal cation binding to bilayer lipid membranes. VINITY, Moscow,
p 1–108
46. WILLIAMS D R 1971 The metals of life: the solution chemistry of
metal ions in biological systems.Van Nostrand-Reinhold. London,
New York, p 1–172
47. RABINOWITZ M B 1991 Toxicokinetics of bone lead Environ.
Health Perspect 91: 33–37
48. TSAIH S W, KORRICK S, SCHWARTZ J, AMARASIRIWAR-
DENA C, ARO A et al. 2004 Lead, diabetes, hypertension, and renal
Period biol, Vol 111, No 1, 2009. 97
Lead as an environmental cardiovascular risk factor A. Omelchenko
function: the normative aging study. Environ Health Perspect 112:
1178–1182
49. HU H, PAYTON M, KORRICK S, ARO A, SPARROW D et al.
1996. Determinants of bone and blood lead levels among commu-
nity-exposed middle-aged to elderly men. The normative aging
study. Am J Epidemiol 144: 749–759
50. YIN X, LIU X, SUN L, ZHU R, XIE Z, WANG Y 2006 A 1500-year
record of lead, copper, arsenic, cadmium, zinc level in Antarctic seal
hairs and sediments. Sci Total Environ 371: 252–257
51. NRIAGU J O 1979 Global inventory of natural and anthropogenic
emissions of trace metals to the atmosphere. Nature 279: 409–411
52. TUZEN M, SOYLAK M, PARLAR K 2005 Cadmium and lead
contamination in tap water samples from Tokat, Turkey. Bull Envi-
ron Contam Toxicol 75: 284-289
53. FERTMANN R, HENTSCHEL S, DENGLER D, JANSSEN U,
LOMMEL A 2004 Lead exposure by drinking water: an epidemio-
logial study in Hamburg, Germany. Int J Hyg Environ Health 207:
235–244
54. QUINN M J, SHERLOCK J C 1990 The correspondence between
U.K. 'action levels' for lead in blood and in water. Food Addit. Contam
7: 387–424
55. TROESKEN W 2006 Lead exposure and eclampsia in Britain,
1883-1934 Environ Res 101: 395–400
56. VILAGINES R, LEROY P 1995 Lead in drinking water, determina-
tion of its concentration and effects of new recommendations of the
World Health Organization (WHO) on public and private networks
management. Bull Acad Natl Med 179: 1393–408
57. ENGLERT N, HORING H 1994 Lead concentration in tap-water
and in blood of selected schoolchildren in southern Saxonia. Toxicol
Lett 72: 325–331
58. STEGAVIK K 1975. An investigation of heavy metal contamination
of drinking water in the city of Trondheim, Norway. Bull Environ
Contam Toxicol 14: 57–60
59. SATHYANARAYANA S, BEAUDET N, OMRI K, KARR C 2006
Predicting children’s blood lead levels from exposure to school drink-
ing water in Seattle, Washington, USA. Ambul Pediatr 6: 288–292
60. BRYANT S D 2004 Lead-contaminated drinking waters in the pub-
lic schools of Philadelphia. J Toxicol Clin Toxicol 42: 287–294
61. US Environmental Protection Agency 1991 Safe Drinking Water Act
Lead and Cooper Rule (LCR). Fed Reg 56: 26460–564
62. ROJAS-LOPEZ M, SANTOS-BURGOA C, RIOS C, HERNAN-
DEZ-AVILA M, ROMIEU I 1994 Use of lead-glazed ceramics is the
main factor associated to high lead in blood levels in two Mexican
rural communities. J Toxicol Environ Health 42: 45–52
63. ROAN S 2005 An unsavory addition to kids’ lunch boxes: lead. Los
Angeles Times.
64. American Academy of Pediatric Committee on Environmental Health
2005 Lead exposure in children: prevention, detection, and manage-
ment. Pediatrics 116: 1036–1046
65. WILHELM M, EBERWEIN G, HOLZER J, BEGEROW J, SU-
GIRI D et al. 2005 Human biomonitoring of cadmium and lead ex-
posure of child-mother pairs from Germany living in the vicinity of
industrial sources. J Trace Elem Med Biol 19: 83–90
66. MAYAN O N, GOMES M J, HENRIQUES A, SILVA S, BE-
GONHA A 2006 Health survey among people living near an aban-
doned mine. A case study: Jales mine, Portugal. Environ Monit Assess
123: 31–40
67. MORTADA W I, SOBH M A, EL-DEFRAWY M M, FARAHAT S
E 2001 Study of lead exposure from automobile exhaust as a risk for
nephrotoxicity among traffic policemen. Am J Nephrol 21: 274–279
68. MANTON W I 1985 Total contribution of airborne lead to blood
lead. Br J Ind Med 42: 168–172
69. NRIAGU J O 1996 A history of global metal pollution. Science 272:
223–224
70. HAMILTON E I 1974 The chemical elements and human morbid-
ity-water, air and places-a study of natural variability. Sci Total Envi-
ron 3: 3–85
71. SCHWARTZ B S, HU H 2007 Adult lead exposure: time for change.
Environ Health Perspect 115: 451–454
72. NAVAS-ACIEN A, SELVIN E, SHARRETT A R, CALDERON-
ARANDA E, SILBERGELD E, GUALLAR E 2004 Lead, cad-
mium, smoking, and increased risk of peripheral arterial disease.
Circulation 109: 3196–201
98 Period biol, Vol 111, No 1, 2009.
A. Omelchenko Lead as an environmental cardiovascular risk factor
